157 related articles for article (PubMed ID: 34325312)
21. A semi-automated LC-MS/MS method for the determination of LCI699, a steroid 11β-hydroxylase inhibitor, in human plasma.
Li W; Luo S; Rebello S; Flarakos J; Tse FL
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():182-93. PubMed ID: 24814004
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the effect of plasma albumin levels on regorafenib-induced hepatotoxicity using a validated liquid chromatography-tandem mass spectrometry method.
Pang YY; Tan YL; Ho HK
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():220-224. PubMed ID: 28750235
[TBL] [Abstract][Full Text] [Related]
23. A highly sensitive LC-MS/MS method to determine novel Bruton's tyrosine kinase inhibitor spebrutinib: application to metabolic stability evaluation.
Abdelhameed AS; Attwa MW; Al-Shaklia NS; Kadi AA
R Soc Open Sci; 2019 Jun; 6(6):190434. PubMed ID: 31312501
[TBL] [Abstract][Full Text] [Related]
24. In vitro metabolic stability and metabolite profiling of TJ0711 hydrochloride, a newly developed vasodilatory β-blocker, using a liquid chromatography-tandem mass spectrometry method.
Huang J; Si L; Fan Z; Hu L; Qiu J; Li G
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3386-92. PubMed ID: 21963275
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
Mooiman KD; Maas-Bakker RF; Rosing H; Beijnen JH; Schellens JH; Meijerman I
Biomed Chromatogr; 2013 Sep; 27(9):1107-16. PubMed ID: 23674377
[TBL] [Abstract][Full Text] [Related]
26. Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry (LC/MS-MS).
Minocha M; Khurana V; Mitra AK
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():85-92. PubMed ID: 22749591
[TBL] [Abstract][Full Text] [Related]
27. An Ultrafast UPLC-MS/MS Method for Characterizing the In Vitro Metabolic Stability of Acalabrutinib.
Attwa MW; Bakheit AH; Abdelhameed AS; Kadi AA
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894699
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a highly sensitive LC-MS/MS-ESI method for quantification of IIIM-019-A novel nitroimidazole derivative with promising action against Tuberculosis: Application to drug development.
Kour G; Chandan BK; Khullar M; Munagala G; Singh PP; Bhagat A; Gupta AP; Vishwakarma RA; Ahmed Z
J Pharm Biomed Anal; 2016 May; 124():26-33. PubMed ID: 26922579
[TBL] [Abstract][Full Text] [Related]
29. Investigation of metabolic stability of the novel ALK inhibitor brigatinib by liquid chromatography tandem mass spectrometry.
Darwish HW; Kadi AA; Attwa MW; Almutairi HS
Clin Chim Acta; 2018 May; 480():180-185. PubMed ID: 29458050
[TBL] [Abstract][Full Text] [Related]
30. A highly efficient and sensitive LC-MS/MS method for the determination of afatinib in human plasma: application to a metabolic stability study.
Kadi AA; Abdelhameed AS; Darwish HW; Attwa MW; Al-Shakliah NS
Biomed Chromatogr; 2016 Aug; 30(8):1248-55. PubMed ID: 26683307
[TBL] [Abstract][Full Text] [Related]
31. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
Ammari WG; Al-Qadhi Z; Khalil M; Tayyem R; Qammaz S; Oriquat G; Basheti IA; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):202-10. PubMed ID: 25229261
[TBL] [Abstract][Full Text] [Related]
32. Novel LC- ESI-MS/MS method for desvenlafaxine estimation human plasma: application to pharmacokinetic study.
Kancharla PK; Kondru VG; Dannana GS
Biomed Chromatogr; 2016 Feb; 30(2):249-55. PubMed ID: 26095112
[TBL] [Abstract][Full Text] [Related]
33. Quantitative determination of capsaicin, a transient receptor potential channel vanilloid 1 agonist, by liquid chromatography quadrupole ion trap mass spectrometry: evaluation of in vitro metabolic stability.
Beaudry F; Vachon P
Biomed Chromatogr; 2009 Feb; 23(2):204-11. PubMed ID: 18816461
[TBL] [Abstract][Full Text] [Related]
34. A rapid and sensitive LC-MS/MS method for evaluation of the absolute oral bioavailability of a novel c-Met tyrosine kinase inhibitor QBH-196 in rats.
Zhang Q; Sun J; Lu T; Zhang J; Wu C; Li L; He Z; Zhao Y; Liu X
Biomed Chromatogr; 2015 Nov; 29(11):1650-6. PubMed ID: 25880630
[TBL] [Abstract][Full Text] [Related]
35. Off-line solid phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of brivaracetam acid metabolites: Method validation and application to in vitro metabolism assays.
Bourgogne E; Culot B; Dell'Aiera S; Chanteux H; Stockis A; Nicolas JM
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():138-145. PubMed ID: 29665472
[TBL] [Abstract][Full Text] [Related]
36. LC-MS/MS method for the determination of clodronate in human plasma.
Hasan M; Schumacher G; Seekamp A; Taedken T; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():341-347. PubMed ID: 25194348
[TBL] [Abstract][Full Text] [Related]
37. A liquid chromatography-tandem mass spectrometry method for the quantitation of actarit in rabbit plasma: application to pharmacokinetics and metabolic stability.
Ramakrishna R; Bhateria M; Puttrevu SK; Durga Prasad Y; Singh R; Bhatta RS
J Mass Spectrom; 2016 Jan; 51(1):69-78. PubMed ID: 26757074
[TBL] [Abstract][Full Text] [Related]
38. Highly sensitive method for the determination of JI-101, a multi-kinase inhibitor in human plasma and urine by LC-MS/MS-ESI: method validation and application to a clinical pharmacokinetic study.
Sharma S; Dubey NK; Dasgupta AK; Sahu M; Benjamin B; Mullangi R; Srinivas NR
Biomed Chromatogr; 2012 Feb; 26(2):232-8. PubMed ID: 21594880
[TBL] [Abstract][Full Text] [Related]
39. Quantification of chlordesmethyldiazepam by liquid chromatography-tandem mass spectrometry: application to a cloxazolam bioequivalence study.
Oliveira-Silva D; Oliveira CH; Mendes GD; Galvinas PA; Barrientos-Astigarraga RE; De Nucci G
Biomed Chromatogr; 2009 Dec; 23(12):1266-75. PubMed ID: 19488979
[TBL] [Abstract][Full Text] [Related]
40. Investigation of metabolic degradation of new ALK inhibitor: Entrectinib by LC-MS/MS.
Attwa MW; Darwish HW; Alhazmi HA; Kadi AA
Clin Chim Acta; 2018 Oct; 485():298-304. PubMed ID: 30006284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
